Cargando…
Chromatography and modification of nucleosides. Part C, Modified nucleosides in cancer and normal metabolism methods and applications /
Modified Nucleosides in Cancer and Normal Metabolism - Methods and Applications.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam :
Elsevier,
1990.
|
| Colección: | Journal of chromatography library ;
v. 45C. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Chromatography and Modification of Nucleosides; Copyright Page; Table of Contents; Preface; A Dedication; Special Acknowledgement to Dr. Robert W. Zumwalt; Editors; Contributors; Chromatography and Modification of Nucleosides: Contents of Parts A, B and D; Introduction: Early Development of Nucleoside Markers for Cancer; Chapter 1. Progress and Future Prospects of Modified Nucleosides as Biological Markers of Cancer; Chapter 2. Ribonucleosides in Biological Fluids by a High-Resolution Quantitative RPLC-UV Method
- Chapter 3. Ribonucleosides in Body Fluids: On-Line Chromatographic Cleanup and Analysis by a Column Switching TechniqueChapter 4. High-Performance Liquid Chromatography of Free Nucleotides, Nucleosides, and their Bases in Biological Samples; Chapter 5. Isolation and Characterization of Modified Nucleosides from Human Urine; Chapter 6. High Performance Liquid Chromatography of Modified Nucleosides in Human Serum; Chapter 7. Modified Nucleosides in Human Blood Serum as Biochemical Signals for Neoplasia; Chapter 8. Biochemical Correlations between Pseudouridine Excretion and Neoplasias
- Chapter 9. High-Performance Liquid Chromatography Analysis of Nucleosides and Bases in Mucosa Tissues and Urine of Gastrointestinal Cancer PatientsChapter 10. Modified Nucleosides as Biochemical Markers of Asbestos Exposure and AIDS; Chapter 11. RNA Catabolites in Health and Disease; Chapter 12. Serum Nucleoside Chromatography for Classification of Lung Cancer Patients and Controls; Chapter 13. Modified Nucleosides and Nucleobases in Urine and Serum as Selective Markers for the Whole-Body Turnover of tRNA, rRNA, and mRNA-Cap
- Future Prospects and Impact